passages.id: split_6_test_802_passage
passages.type: progene_text
passages.text: Treatment of PC12 cells with IGF-I enhanced the bcl-2 promoter activity by 2.3 - fold , which was inhibited significantly ( p < 0.01 ) by SB203580 , an inhibitor of p38 mitogen - activated protein kinase ( MAPK ) .